Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

Biocon cancels plans to market Novo Nordisk generics in China due to local competition, focusing on other markets.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Wall Street is getting worried about United Airlines. Yes, it's mostly about Newark airport. United has a major hub at Newark Liberty International Airport, and Wall Street wonders just how much the ...

If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...

A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...

A US study by the Centers for Disease Control reveals the drug hospitalises nearly 70 people daily in America. CEO of Calocurb, a natural appetite suppressant company, Sarah Kennedy, says this is ...

India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move ...